Cirrhosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 46: | Line 46: | ||
|bgcolor="Beige"|[[rashes]], organ tissue damage, contact sensitivity. | |bgcolor="Beige"|[[rashes]], organ tissue damage, contact sensitivity. | ||
|- |} | |- |} | ||
===Differentiating Cirrhosis from other Diseases Based on Ascitic Fluid=== | ===Differentiating Cirrhosis from other Diseases Based on Ascitic Fluid=== |
Revision as of 15:41, 7 September 2012
Cirrhosis Microchapters |
Diagnosis |
---|
Treatment |
Case studies |
Cirrhosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Cirrhosis differential diagnosis |
Risk calculators and risk factors for Cirrhosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Differentiating Cirrhosis from other Diseases
Differentiating Cirrhosis from other Diseases Based on Ascitic Fluid
Ascites may be caused by portal hypertension due to cirrhosis of liver or due to other causes like malignancies etc.,
Ascitic fluid analysis should be done to broadly categorize the cause of ascites.
Ascites is broadly classified as two types based on the serum-ascites albumin gradient (SAAG):
- Transudate - SAAG > 1.1 g/dL (indicates the ascites is due to portal hypertension).
- Exudate - SAAG < 1.1 g/dL (indicates the ascites is due to non-portal hypertension etiology).
References
Condition | Differentiating Signs and Symptoms | Differentiating Tests |
Constrictive pericarditis | Immediate onset caused by IgE binding to mast cells causing degranulation and release of histamine. | Urticaria, anaphylaxis, angioedema, bronchospasm. |
Budd-Chiari Syndrome | Delayed onset reaction caused by IgG or IgM antibodies, directed at drug-hapten coated cells. | Thrombocytopenia, anemia, cytopenia. |
Splenic vein thrombosis | Delayed in onset and caused by IgG immune complex formation and deposition, and complement activation. | Vasculitis, serum sickness, arthralgia, fever, rash. |
Portal vein thrombosis | The presentation of drug molecules by major histocompatability complexes to T cells, causing the release of cytokines and other inflammatory mediators. Also associated with the activation of eosinophils, monocytes, and neutrophils. | rashes, organ tissue damage, contact sensitivity. |
Schistosomiasis | The presentation of drug molecules by major histocompatability complexes to T cells, causing the release of cytokines and other inflammatory mediators. Also associated with the activation of eosinophils, monocytes, and neutrophils. | rashes, organ tissue damage, contact sensitivity. |
Sarcoidosis | The presentation of drug molecules by major histocompatability complexes to T cells, causing the release of cytokines and other inflammatory mediators. Also associated with the activation of eosinophils, monocytes, and neutrophils. | rashes, organ tissue damage, contact sensitivity. |
Inferior vena cava obstruction | The presentation of drug molecules by major histocompatability complexes to T cells, causing the release of cytokines and other inflammatory mediators. Also associated with the activation of eosinophils, monocytes, and neutrophils. | rashes, organ tissue damage, contact sensitivity. |